Company / Total Assets
Entera Bio Ltd. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$16.0M
FY2025
5-year range
$9.4M / $26.0M
FY2021-FY2025
Trend
+70.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 3 years of decline, reaching $16M.
Based on SEC 10-K filings.
$16M in FY2025 with a 3-year CAGR of +6.8%.
Improved from $12M to $16M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, total assets increased 70.3% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.0M | +70.3% |
| FY2024 | $9.4M | -20.2% |
| FY2023 | $11.8M | -10.4% |
| FY2022 | $13.1M | -49.5% |
| FY2021 | $26.0M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026